We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Treatment Shown to Reverse Stroke

By HospiMedica staff writers
Posted on 06 May 2002
A clinical trial has demonstrated that doctors can reverse stroke in a patient through the use of a clot retrieval device. More...
The trial was conducted at the Mid-America Brain and Stroke Institute at St. Luke's Hospital (Kansas City, KS, USA).

The patient in the trial developed signs of stroke and rushed to the hospital, where stroke was diagnosed. Doctors used a clot retrieval device with a corkscrew-like microwire to treat the patient. A catheter was inserted into an artery of the patient, and the microwire was threaded through the artery and up into the brain, guided by biplane angiography. The corkscrew was used to snare the clot and remove it from the brain to reverse the stroke.

The patient was able to go home five days later and has recovered completely. Unlike the three-hour window for using clot-busting drugs, this new treatment for strokes has an eight-hour window, which increases the number of patients eligible for treatment. Other US sites are also studying treatment with the device, called the Concentric Merci Retriever System.

"The new mechanical clot retrieval device removes the blockage just as you would remove a plug in your drainpipe,” said Marilyn Rymer, M.D., neurologist and medical director of the stroke center at St. Luke's. "This will makes stroke reversal possible for people who are too late to receive tPA (tissue plasminogen activator) or who can't receive it because it is too risky, such as patients advanced in age or who have had a recent surgery.”




Related Links:
St. Luke's Hospital

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.